Francesco Della Ferrera
YOU?
Author Swipe
View article: A Multi-Center Observation Study on Medication-Related Osteonecrosis of the Jaw (MRONJ) in Patients with Osteoporosis, and Other Non-Malignant Bone Diseases, in Northwestern Italy over 16 Years
A Multi-Center Observation Study on Medication-Related Osteonecrosis of the Jaw (MRONJ) in Patients with Osteoporosis, and Other Non-Malignant Bone Diseases, in Northwestern Italy over 16 Years Open
Objectives: To assess the number of new cases of Medication-Related Osteonecrosis of the Jaw (MRONJ) among patients with osteoporosis and other non-malignant bone diseases in Northwestern Italy between 2007 and 2022. Methods: MRONJ cases w…
View article: M-TOR INHIBITORS & MRONJ. POSSIBLE ROLE OF EVEROLIMUS IN A CASE OF RECURRENT MANDIBULAR OSTEONECROSIS
M-TOR INHIBITORS & MRONJ. POSSIBLE ROLE OF EVEROLIMUS IN A CASE OF RECURRENT MANDIBULAR OSTEONECROSIS Open
INTRODUCTION: Concomitant therapy with antiresorptive/antiangiogenic drugs is common in cancer management and is reported to have a modifying effect on MRONJ development. M-TOR inhibitors have antiangiogenic and immunosuppressive propertie…
View article: DENTAL EXTRACTION & DENOSUMAB. EVALUATION OF PIEZOELECTRIC SURGICAL PROTOCOL FOR MRONJ PREVENTION. PRELIMINARY REPORT.
DENTAL EXTRACTION & DENOSUMAB. EVALUATION OF PIEZOELECTRIC SURGICAL PROTOCOL FOR MRONJ PREVENTION. PRELIMINARY REPORT. Open
AIM: To evaluate incidence of wound healing complications and MRONJ following tooth extractions in patients treated with Denosumab (Dmab). MATERIALS AND METHODS: Atraumatic piezosurgery-aided tooth extractions in Dmab treated patients duri…
View article: OSTEONECROSIS OF JAW (ONJ) IN PATIENTS WITH OSTEOPOROSIS AND OTHER NON-MALIGNANT DISEASES IN PIEDMONT AND AOSTA VALLEY 2004-2018
OSTEONECROSIS OF JAW (ONJ) IN PATIENTS WITH OSTEOPOROSIS AND OTHER NON-MALIGNANT DISEASES IN PIEDMONT AND AOSTA VALLEY 2004-2018 Open
Osteonecrosis of the Jaws (ONJ) related to bisphosphonates (BPs) or denosumab is a concern for osteoporosis and Rheumatoid Arthritis (RA) patients. In a context of increasing prescription rate of BPs and denosumab amid those patients in th…
View article: OSTEONECROSIS OF THE JAW (ONJ) IN CANCER AND MYELOMA PATIENTS. A 16-YEAR EXPERIENCE OF “RETE ONCOLOGICA PIEMONTE–VALLE D’AOSTA” CANCER NETWORK
OSTEONECROSIS OF THE JAW (ONJ) IN CANCER AND MYELOMA PATIENTS. A 16-YEAR EXPERIENCE OF “RETE ONCOLOGICA PIEMONTE–VALLE D’AOSTA” CANCER NETWORK Open
Incidence of Medication-Related Osteonecrosis of the Jaw (MRONJ) related to cancer and myeloma treatments is yet to be assessed, with scarce epidemiologic data available from surveys of limited investigated populations. A 16-year (Jan 1 st…